Small Molecule CDMO
Product Description
ST Pharm Co. Ltd
-
KR -
2015On CPHI since
-
4Certificates
-
500 - 999Employees
Company types
Primary activities
Categories
Specifications
ST Pharm Co. Ltd
-
KR
-
2015On CPHI since
-
4Certificates
-
500 - 999Employees
Company types
Primary activities
More Products from ST Pharm Co. Ltd (99)
-
Product N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-O-(TBDMS)-L-guanosine 3'-O-(2-cyanoethyl N,N-Diisopropylphosphoramidite)
ST Pharm provides a wide range of (L) RNA-(TBS) amidites products which includes N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-O-(TBDMS)-L-guanosine 3'-O-(2-cyanoethyl N,N-Diisopropylphosphoramidite). It belongs to specialty amidites category. Contact us for more information. -
Product N2-Isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-O-(TBDMS)guanosine 3'-O-(2-cyanoethyl N,N-Diisopropylphosphoramidite)
ST Pharm provides a wide range of RNA (TBS)-amidites products which includes N2-isobutyryl-5'-O-(4,4'-dimethoxytrityl)-2'-O-(TBDMS)guanosine 3'-O-(2-cyanoethyl N,N-diisopropylphosphoramidite). It belongs to standard amidites category. Contact us for more information. -
Product Generic / Monomer
1. Generic ST Pharm focusing on technical challenging and brand generics. We specialize in MRI contrast agents and and possess a portfolio of tuberculosis and anti-infectious drugs as generic APIs. 2. Monomer ST Pharm offers a one-stop service from nucleosides to phosphoramidites with specialty and commo... -
Product mRNA CDMO
ST Pharm provides mRNA CDMO service from custom mRNA IVT synthesis to lipid nanoparticle (LNP) formulation with its own IP on two key mRNA platform technologies, SmartCap (proprietary 5'-capping) and STLNP (LNP with novel ionizable lipid). We are able to manufacture in GMP/non-GMP grade, and able to suppo... -
Product Oligonucleotide CDMO
ST Pharm offers top-tier customized oligonucleotide CDMO services under stringent cGMP conditions. We enhance raw material supply chain resilience by leveraging in-house manufacturing capabilities of nucleosides/phosphormaidites. Our two state-of-the-art facilities, expected to reach a 7.0 mol capacity b... -
Product (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ((1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate [VVC]
ST Pharm provides a wide range of pharmaceutical products which includes (2R,3S)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol ((1R,4S)-7,7-dimethyl-2-oxobicyclo[2.2.1]heptan-1-yl)methanesulfonate [VVC]. It belongs to anit-virals & CNS category. Contact us for more i... -
Product (2R,3S)-3-(tert-butoxycarbonyl)amino-4-phenylbutane-1,2-diol [SEP-8]
ST Pharm provides a wide range of pharmaceutical products which includes (2R,3S)-3-(tert-butoxycarbonyl)amino-4-phenylbutane-1,2-diol [SEP-8]. It belongs to anit-virals & CNS category. Contact us for more information. -
Product (2R,3S)-N-(Benzyloxycarbonyl)-3-amino-1,2-epoxy-4-phenylbutane [RCEP]
ST Pharm provides a wide range of pharmaceutical products which includes (2R,3S)-N-(benzyloxycarbonyl)-3-amino-1,2-epoxy-4-phenylbutane [RCEP]. It belongs to anit-virals & CNS category. Contact us for more information. -
Product (2R,3S)-N-(tert-butoxycarbonyl)-3-amino-1,2
ST Pharm provides a wide range of pharmaceutical products which includes (2R,3S)-N-(tert-butoxycarbonyl)-3-amino-1,2. It belongs to anit-virals & CNS category. Contact us for more information. -
Product (3R,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid tert-butyl ester
ST Pharm provides a wide range of pharmaceutical products which includes (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid tert-butyl ester. It belongs to Cardiovascular category. Contact us for more information. -
Product (3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)]-2-[methyl(methylsulfonyl) amino-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid tert-butyl ester [RDT]
ST Pharm provides a wide range of pharmaceutical products which includes (3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)]-2-[methyl(methylsulfonyl) amino-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid tert-butyl ester [RDT]. It belongs to Cardiovascular category. Contact us for more information.
ST Pharm Co. Ltd resources (2)
-
News ST Pharm to construct second oligonucleotide facility in Korea
The expansion is expected to make the company the largest CDMO in oligonucleotide production in 2025 -
Video ST Pharm Coporate Video (Company introduction)
ST Pharm, we are the innovative company saving lives. As a reliable CDMO partner, ST Pharm offers comprehensive contract development and manufacturing services. As your trusted partner, we will take you on a journey to explore the core values and capabilities that define our company.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance